467 related articles for article (PubMed ID: 33847835)
21. Hippo signaling impairs alveolar epithelial regeneration in pulmonary fibrosis.
Warren R; Lyu H; Klinkhammer K; De Langhe SP
Elife; 2023 May; 12():. PubMed ID: 37166104
[TBL] [Abstract][Full Text] [Related]
22. Myofibroblast Ccn3 is regulated by Yap and Wwtr1 and contributes to adverse cardiac outcomes.
Flinn MA; Alvarez-Argote S; Knas MC; Almeida VA; Paddock SJ; Zhou X; Buddell T; Jamal A; Taylor R; Liu P; Drnevich J; Patterson M; Link BA; O'Meara CC
Front Cardiovasc Med; 2023; 10():1142612. PubMed ID: 36998974
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.
Umbarkar P; Tousif S; Singh AP; Anderson JC; Zhang Q; Tallquist MD; Woodgett J; Lal H
Circ Res; 2022 Sep; 131(7):620-636. PubMed ID: 36052698
[TBL] [Abstract][Full Text] [Related]
24. DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer.
Wang D; Li Z; Li X; Yan C; Yang H; Zhuang T; Wang X; Zang Y; Liu Z; Wang T; Jiang R; Su P; Zhu J; Ding Y
J Exp Clin Cancer Res; 2022 Jul; 41(1):219. PubMed ID: 35820928
[TBL] [Abstract][Full Text] [Related]
25. Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers.
Soyama H; Nishio M; Otani J; Sakuma T; Takao S; Hara S; Masuda T; Mimori K; Toyokuni S; Lydon JP; Nakao K; Nishina H; Fukumoto T; Maehama T; Suzuki A
Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2123134119. PubMed ID: 35858357
[TBL] [Abstract][Full Text] [Related]
26. Sirtuin 6 protects against hepatic fibrogenesis by suppressing the YAP and TAZ function.
Chowdhury K; Huang M; Kim HG; Dong XC
FASEB J; 2022 Oct; 36(10):e22529. PubMed ID: 36036554
[TBL] [Abstract][Full Text] [Related]
27. FAT1 cadherin acts upstream of Hippo signalling through TAZ to regulate neuronal differentiation.
Ahmed AF; de Bock CE; Lincz LF; Pundavela J; Zouikr I; Sontag E; Hondermarck H; Thorne RF
Cell Mol Life Sci; 2015 Dec; 72(23):4653-69. PubMed ID: 26104008
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA lncPostn links TGF-β and p53 signaling pathways to transcriptional regulation of cardiac fibrosis.
Tao L; Qin Z; Lin L; Guo H; Liang Z; Wang T; Xu J; Xu M; Hua F; Su X
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C457-C472. PubMed ID: 38145299
[TBL] [Abstract][Full Text] [Related]
29. Regulators of cardiac fibroblast cell state.
Bretherton R; Bugg D; Olszewski E; Davis J
Matrix Biol; 2020 Sep; 91-92():117-135. PubMed ID: 32416242
[TBL] [Abstract][Full Text] [Related]
30. Lactoferrin attenuates cardiac fibrosis and cardiac remodeling after myocardial infarction via inhibiting mTORC1/S6K signaling pathway.
Ye T; Yan Z; Chen C; Wang D; Wang A; Li T; Yang B; Ding X; Shen C
Theranostics; 2023; 13(10):3419-3433. PubMed ID: 37351157
[No Abstract] [Full Text] [Related]
31. The Hippo signaling pathway: from multiple signals to the hallmarks of cancers.
Zhu N; Yang R; Wang X; Yuan L; Li X; Wei F; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(6):904-913. PubMed ID: 36942989
[TBL] [Abstract][Full Text] [Related]
32. New Insights into Hippo/YAP Signaling in Fibrotic Diseases.
Mia MM; Singh MK
Cells; 2022 Jun; 11(13):. PubMed ID: 35805148
[TBL] [Abstract][Full Text] [Related]
33. The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises.
Ortega Á; Vera I; Diaz MP; Navarro C; Rojas M; Torres W; Parra H; Salazar J; De Sanctis JB; Bermúdez V
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008857
[TBL] [Abstract][Full Text] [Related]
34. Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction.
Venugopal H; Hanna A; Humeres C; Frangogiannis NG
Cells; 2022 Apr; 11(9):. PubMed ID: 35563692
[TBL] [Abstract][Full Text] [Related]
35. Reduction of Cardiac Fibrosis by Interference With YAP-Dependent Transactivation.
Garoffolo G; Casaburo M; Amadeo F; Salvi M; Bernava G; Piacentini L; Chimenti I; Zaccagnini G; Milcovich G; Zuccolo E; Agrifoglio M; Ragazzini S; Baasansuren O; Cozzolino C; Chiesa M; Ferrari S; Carbonaro D; Santoro R; Manzoni M; Casalis L; Raucci A; Molinari F; Menicanti L; Pagano F; Ohashi T; Martelli F; Massai D; Colombo GI; Messina E; Morbiducci U; Pesce M
Circ Res; 2022 Jul; 131(3):239-257. PubMed ID: 35770662
[TBL] [Abstract][Full Text] [Related]
36. PBX/Knotted 1 homeobox-2 (PKNOX2) is a novel regulator of myocardial fibrosis.
Chen L; Li H; Liu X; Zhang N; Wang K; Shi A; Gao H; Akdis D; Saguner AM; Xu X; Osto E; Van de Veen W; Li G; Bayés-Genís A; Duru F; Song J; Li X; Hu S
Signal Transduct Target Ther; 2024 Apr; 9(1):94. PubMed ID: 38644381
[TBL] [Abstract][Full Text] [Related]
37. AR activates YAP/TAZ differentially in prostate cancer.
Salem O; Jia S; Qian BZ; Hansen CG
Life Sci Alliance; 2023 Sep; 6(9):. PubMed ID: 37385752
[TBL] [Abstract][Full Text] [Related]
38. M2 macrophages promote subconjunctival fibrosis through YAP/TAZ signalling.
Wang Y; Geng X; Guo Z; Chu D; Liu R; Cheng B; Cui H; Li C; Li J; Li Z
Ann Med; 2024 Dec; 56(1):2313680. PubMed ID: 38335557
[TBL] [Abstract][Full Text] [Related]
39. YAP/TAZ: Molecular pathway and disease therapy.
Wei Y; Hui VLZ; Chen Y; Han R; Han X; Guo Y
MedComm (2020); 2023 Aug; 4(4):e340. PubMed ID: 37576865
[TBL] [Abstract][Full Text] [Related]
40. TAZ/WWTR1 mediates liver mesothelial-mesenchymal transition induced by stiff extracellular environment, TGF-β1, and lysophosphatidic acid.
Lua I; Balog S; Asahina K
J Cell Physiol; 2022 May; 237(5):2561-2573. PubMed ID: 35445400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
